rd13-01

Cell therapyexperimental

Clinical trial activity

10 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
8
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2020 (NCT04538599)

Timeline

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07142161Early Phase 1 (Phase 1)Jul 20, 2025Nanjing Bioheng Biotech Co., Ltd.
NCT06732492Phase 1Oct 31, 2024Huazhong University of Science and Technology, Nanjing Bioheng Biotech Co., Ltd.
NCT06622694Phase 1Oct 7, 2024China Academy of Chinese Medical Sciences, Nanjing Bioheng Biotech Co., Ltd.
NCT05923541Early Phase 1 (Phase 1)Jun 30, 2023Henan Medical University, Nanjing Bioheng Biotech Co., Ltd.
NCT05902845Early Phase 1 (Phase 1)Apr 30, 2023Anhui Medical University, Nanjing Bioheng Biotech Co., Ltd.
NCT05895994Early Phase 1 (Phase 1)Mar 10, 2023Huazhong University of Science and Technology, Nanjing Bioheng Biotech Co., Ltd.
NCT05907603Early Phase 1 (Phase 1)Mar 8, 2023Nanjing Bioheng Biotech Co., Ltd., Xuzhou Medical University
NCT05716113Early Phase 1 (Phase 1)Feb 15, 2023Nanjing Bioheng Biotech Co., Ltd., Zhejiang University
NCT04620655N/ANov 15, 2020Hebei Yanda Ludaopei Hospital, Ludaopei Hospital
NCT04538599N/ASep 1, 2020Zhejiang University
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Nanjing Bioheng Biotech Co., Ltd.For profit8112023
Huazhong University of Science and TechnologyAcademic/Hospital2212023
Zhejiang UniversityAcademic/Hospital2222020
Anhui Medical UniversityAcademic/Hospital1112023
China Academy of Chinese Medical SciencesAcademic/Hospital1112024
Hebei Yanda Ludaopei HospitalAcademic/Hospital1112020
Henan Medical UniversityAcademic/Hospital1112023
Ludaopei HospitalAcademic/Hospital1012020
Xuzhou Medical UniversityAcademic/Hospital1112023
9 organizations
Page 1 / 1